Page last updated: 2024-08-23

paclitaxel and Lupus Erythematosus, Cutaneous, Subacute

paclitaxel has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belum, VR; Dalenc, F; Deslandres, M; Eche, A; Gladieff, L; Lacouture, ME; Lebœuf, NR; Montastruc, M; Roche, H; Sibaud, V; Vigarios, E1
Bagot, M; Cosnes, A; Duong, TA; Gantzer, A; Ortonne, N; Regnier, S; Wolkenstein, P1
Cary-Ten Have Dallinga, M; El Kouri, C; Lortholary, A; Morineau, N; Ramée, JF1
Adachi, A; Horikawa, T1

Reviews

2 review(s) available for paclitaxel and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Dermatological adverse events with taxane chemotherapy.
    European journal of dermatology : EJD, 2016, Oct-01, Volume: 26, Issue:5

    Topics: Alopecia; Antineoplastic Agents; Docetaxel; Drug Eruptions; Edema; Humans; Lupus Erythematosus, Cutaneous; Nail Diseases; Paclitaxel; Pigmentation Disorders; Radiodermatitis; Taxoids

2016
[Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
    Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:5

    Topics: Adenocarcinoma; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bevacizumab; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Mastectomy; Middle Aged; Paclitaxel; Paraneoplastic Syndromes; Ribonucleoproteins; Salvage Therapy; Tamoxifen; Taxoids; Trastuzumab

2011

Other Studies

2 other study(ies) available for paclitaxel and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
[Paclitaxel-induced lupus].
    Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:9 Pt 1

    Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antineoplastic Agents, Phytogenic; Betamethasone; Biopsy; Drug Therapy, Combination; Erythropoietin; Female; Humans; Lupus Erythematosus, Cutaneous; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Recurrence; Skin; Treatment Outcome

2007
Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody.
    The Journal of dermatology, 2007, Volume: 34, Issue:7

    Topics: Antibodies, Antinuclear; Antineoplastic Agents, Phytogenic; Arm; Breast Neoplasms; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Paclitaxel; Sjogren's Syndrome; Skin

2007